25th July 2015 - New research

DIABETIC DRUG REDUCES THE RISK OF PARKINSON'S DISEASE

Glitazones, which are diabetic drugs, have been found to be associated with a 28% reduction in the risk of developing Parkinson's Disease. Glitazones are peroxisome proliferation activated receptor gamma agonists. For more information go to : Glitazones

Diabetics, who did not have Parkinson's Disease, who were prescribed Glitazones, were compared with people taking other diabetic drugs. Their progress was recorded until they received a diagnosis of Parkinson's Disease. The incidence of Parkinson's Disease was 6.4 per 100,000 in those taking Glitazones and 8.8 in those taking other diabetic drugs. This is the equivalent of a 28% reduction in the risk of developing Parkinson's Disease when taking Glitazones. However, the authors point out that glitazones have been associated with some serious side effects.

Another diabetic drug, Exenatide was previously found to improve Parkinson's Disease. As with Glitazones, the authors did not suggest how this diabetes drug can have effect in Parkinson's Disease. For more information go to : Exenatide

Reference : PLoS Medicine [2015] 12(7) : e1001854 (R.Brauer, K.Bhaskaran, N.Chaturvedi, D.T.Dexter, L.Smeeth, I.Douglas)  Complete abstract  For more news go to Parkinson's Disease News

E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new articles are added to Parkinson's Disease News,  please merely e-mail [email protected] with the message "subscribe".  No form of identity is required.  E-mail addresses are not used for any other purpose.